Levoreact Oftalmico

Levocabastine Hydrochloride, the active ingredient in Levoreact Oftalmico, is a H1 receptor antagonist presented as an ophthalmic solution for ocular use. It alleviates itching, redness and swelling caused by allergic eye conditions in patients with allergic conjunctivitis and related disorders.

GNH USA supplies Levoreact Oftalmico as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levocabastine Hydrochloride is used to manage ocular allergic reactions by blocking histamine H1 receptors. - Allergic conjunctivitis: reduces itching, redness and swelling. - Seasonal allergic eye disease: provides rapid symptom relief. - Vernal keratoconjunctivitis: eases ocular discomfort and inflammation.

Common Side Effects: - Transient burning or stinging sensation on instillation. - Mild ocular redness or hyperemia. - Temporary blurred vision. - Increased tearing. - Mild headache. - Slight eye discomfort.

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis) with swelling and difficulty breathing. - Corneal ulceration or epithelial defect. - Persistent ocular pain or photophobia. - Vision loss or significant visual disturbance. - Severe intraocular inflammation.

Levocabastine ophthalmic solution should be used with caution in the following situations: - Known hypersensitivity to levocabastine or any excipient: discontinue use. - Pre‑existing ocular infection or severe inflammation: avoid unless directed by a specialist. - Patients with glaucoma or ocular hypertension: monitor intra‑ocular pressure. - Pregnancy and breastfeeding: safety not established; consult a physician. - Store at room temperature (below 25°C): keep in original container, protect from moisture and light.

Levocabastine ophthalmic solution may interact with other ocular medications. Major Interactions (Avoid): - Concurrent use of other topical antihistamines: may increase ocular irritation. - Combination with vasoconstrictive decongestants: risk of excessive local vasoconstriction. Moderate Interactions (Monitor Closely): - Systemic antihistamines: possible reduction of levocabastine efficacy. - Contact lens wear: may cause increased discomfort or lens deposits. - Co‑administration with ophthalmic corticosteroids: monitor for additive anti‑inflammatory effects.